Is Curaleaf going to shake off the FUD from the FDA & continue crush the U.S market.
I think so, although they may have stepped over some boundaries with promotion / labeling & making claims on some of their cbd products, it doesn't change the position they have in the U.S with distribution.
It looks like CURA may have found a double bottom?
Time will tell per usual.
